These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 20557066)
1. Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. Liang M; Liu X; Cheng D; Liu G; Dou S; Wang Y; Rusckowski M; Hnatowich DJ Bioconjug Chem; 2010 Jul; 21(7):1385-8. PubMed ID: 20557066 [TBL] [Abstract][Full Text] [Related]
2. Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In. Liu X; Wang Y; Nakamura K; Kawauchi S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ J Nucl Med; 2009 Apr; 50(4):582-90. PubMed ID: 19289423 [TBL] [Abstract][Full Text] [Related]
3. Tumor delivery of antisense oligomer using trastuzumab within a streptavidin nanoparticle. Wang Y; Liu X; Chen L; Cheng D; Rusckowski M; Hnatowich DJ Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1977-86. PubMed ID: 19572130 [TBL] [Abstract][Full Text] [Related]
4. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker. Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353 [TBL] [Abstract][Full Text] [Related]
5. Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation. Liu Y; Cheng D; Liu X; Liu G; Dou S; Xiao N; Chen L; Rusckowski M; Hnatowich DJ Nucl Med Biol; 2012 Jan; 39(1):101-7. PubMed ID: 21958854 [TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates. Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506 [TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin. Yao Z; Zhang M; Axworthy DB; Wong KJ; Garmestani K; Park L; Park CW; Mallett RW; Theodore LJ; Yau EK; Waldmann TA; Brechbiel MW; Paik CH; Pastan I; Carrasquillo JA Cancer Res; 2002 Oct; 62(20):5755-60. PubMed ID: 12384535 [TBL] [Abstract][Full Text] [Related]
8. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose. Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198 [TBL] [Abstract][Full Text] [Related]
9. Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy. Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5572s-5576s. PubMed ID: 17875791 [TBL] [Abstract][Full Text] [Related]
10. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein. Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250 [TBL] [Abstract][Full Text] [Related]
12. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes. Pan H; Han L; Chen W; Yao M; Lu W J Control Release; 2008 Feb; 125(3):228-35. PubMed ID: 18022270 [TBL] [Abstract][Full Text] [Related]
13. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture. Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463 [TBL] [Abstract][Full Text] [Related]
14. A nanoparticle for tumor targeted delivery of oligomers. Liu X; Wang Y; Hnatowich DJ Methods Mol Biol; 2011; 764():91-105. PubMed ID: 21748635 [TBL] [Abstract][Full Text] [Related]
15. Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery. Liu X; Wang Y; Nakamura K; Kubo A; Hnatowich DJ Cancer Gene Ther; 2008 Feb; 15(2):126-32. PubMed ID: 18084241 [TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420 [TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and biological evaluation of a streptavidin-chimeric t84.66 conjugate for antibody pretargeting. Jia F; Shelton TD; Lewis MR Cancer Biother Radiopharm; 2007 Oct; 22(5):654-64. PubMed ID: 17979568 [TBL] [Abstract][Full Text] [Related]
18. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide. Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129 [TBL] [Abstract][Full Text] [Related]
19. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo. Lee CM; Jang D; Kim J; Cheong SJ; Kim EM; Jeong MH; Kim SH; Kim DW; Lim ST; Sohn MH; Jeong YY; Jeong HJ Bioconjug Chem; 2011 Feb; 22(2):186-92. PubMed ID: 21243999 [TBL] [Abstract][Full Text] [Related]